1.08
Precedente Chiudi:
$1.09
Aprire:
$1.07
Volume 24 ore:
192.92K
Relative Volume:
0.48
Capitalizzazione di mercato:
$112.83M
Reddito:
$241.52M
Utile/perdita netta:
$-199.30M
Rapporto P/E:
-0.8608
EPS:
-1.2546
Flusso di cassa netto:
$37.06M
1 W Prestazione:
-0.92%
1M Prestazione:
-5.26%
6M Prestazione:
-67.57%
1 anno Prestazione:
-61.29%
Definitive Healthcare Corp Stock (DH) Company Profile
Nome
Definitive Healthcare Corp
Settore
Industria
Telefono
508-720-4224
Indirizzo
492 OLD CONNECTICUT PATH, SUITE 401, FRAMINGHAM
Compare DH vs VEEV, TEM, BTSG, HQY, WAY
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
DH
Definitive Healthcare Corp
|
1.08 | 112.83M | 241.52M | -199.30M | 37.06M | -1.2546 |
|
VEEV
Veeva Systems Inc
|
173.98 | 28.42B | 3.20B | 908.91M | 1.39B | 5.4168 |
|
TEM
Tempus Ai Inc
|
47.39 | 8.47B | 1.27B | -245.03M | -245.36M | -1.4071 |
|
BTSG
Brightspring Health Services Inc
|
43.10 | 8.28B | 12.91B | 104.80M | 394.69M | 0.8769 |
|
HQY
Healthequity Inc
|
84.67 | 7.15B | 1.31B | 215.20M | 408.32M | 2.4627 |
|
WAY
Waystar Holding Corp
|
23.74 | 4.55B | 1.10B | 112.09M | 283.19M | 0.6096 |
Definitive Healthcare Corp Stock (DH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-05-09 | Downgrade | BTIG Research | Buy → Neutral |
| 2025-01-13 | Downgrade | Barclays | Equal Weight → Underweight |
| 2024-12-20 | Iniziato | Stephens | Equal-Weight |
| 2024-09-17 | Iniziato | BTIG Research | Buy |
| 2024-07-31 | Downgrade | JP Morgan | Neutral → Underweight |
| 2024-05-08 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2024-01-17 | Downgrade | Needham | Buy → Hold |
| 2024-01-05 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2023-07-24 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2023-04-19 | Iniziato | William Blair | Outperform |
| 2022-12-09 | Iniziato | BofA Securities | Neutral |
| 2022-07-06 | Iniziato | Needham | Buy |
| 2022-04-01 | Ripresa | Credit Suisse | Neutral |
| 2022-02-24 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2021-12-16 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2021-12-02 | Iniziato | Jefferies | Buy |
| 2021-11-17 | Iniziato | Robert W. Baird | Outperform |
| 2021-10-11 | Iniziato | Barclays | Equal Weight |
| 2021-10-11 | Iniziato | Canaccord Genuity | Hold |
| 2021-10-11 | Iniziato | Credit Suisse | Neutral |
| 2021-10-11 | Iniziato | Deutsche Bank | Hold |
| 2021-10-11 | Iniziato | Goldman | Neutral |
| 2021-10-11 | Iniziato | JP Morgan | Neutral |
| 2021-10-11 | Iniziato | Morgan Stanley | Equal-Weight |
| 2021-10-11 | Iniziato | Raymond James | Mkt Perform |
| 2021-10-11 | Iniziato | Stifel | Buy |
Mostra tutto
Definitive Healthcare Corp Borsa (DH) Ultime notizie
Definitive Healthcare Corp. Files Form 8-K with SEC on March 30, 2026 – Company Details and Filing Information - minichart.com.sg
Definitive Healthcare director Jeff Haywood resigns from board and committee - Investing.com
Definitive Healthcare (DH) CEO has RSU shares withheld for taxes - Stock Titan
Definitive Healthcare (DH) chair has 45,154 shares withheld for RSU tax obligations - Stock Titan
Jeff Haywood resigns from Definitive Healthcare board, leaves Compensation Committee - TradingView
Director Jeff Haywood exits Definitive Healthcare (DH) board, shrinking seats - Stock Titan
Definitive Healthcare Corp. Hits New 52-Week Low at $1.37 - Markets Mojo
DH Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
DH Should I Buy - Intellectia AI
Analysts Offer Insights on Healthcare Companies: Definitive Healthcare Corp (DH) and Biogen (BIIB) - The Globe and Mail
Barclays Has Lowered Expectations for Definitive Healthcare (NASDAQ:DH) Stock Price - marketbeat.com
Definitive Healthcare (DH) price target decreased by 29.12% to 2.82 - MSN
DH Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Bearish Setup: Will Definitive Healthcare Corp benefit from current market trends2026 Trends & Verified Short-Term Trading Plans - baoquankhu1.vn
Definitive Healthcare Corp. (NASDAQ:DH) Given Average Rating of “Reduce” by Brokerages - Defense World
Definitive Healthcare Corp. (NASDAQ:DH) Given Average Rating of "Reduce" by Brokerages - MarketBeat
Definitive Healthcare Corp. (DH) matches Q4 earnings estimates - MSN
Analysts Offer Insights on Healthcare Companies: Healthequity (HQY) and Intuitive Surgical (ISRG) - The Globe and Mail
Definitive Healthcare (NASDAQ:DH) Upgraded by Wall Street Zen to Buy Rating - MarketBeat
Institution Moves: Is Definitive Healthcare Corp forming a double bottom2026 Selloffs & Entry Point Confirmation Signals - baoquankhu1.vn
Analysts Offer Insights on Healthcare Companies: Definitive Healthcare Corp (DH), Myomo (MYO) and OS Therapies Incorporated (OSTX) - The Globe and Mail
Definitive Healthcare stock holds at Neutral as revenue declines persist By Investing.com - Investing.com Australia
Definitive Healthcare stock holds at Neutral as revenue declines persist - Investing.com
Definitive Healthcare (NASDAQ:DH) Cut to Strong Sell at Zacks Research - Defense World
AI Investing InsightsOfficial HomepageIntellectia AI™ - Intellectia AI
Definitive Healthcare Corp. Hits New 52-Week Low at $1.10 - Markets Mojo
Zacks Research Downgrades Definitive Healthcare (NASDAQ:DH) to Strong Sell - MarketBeat
Top 3 Health Care Stocks That Could Lead To Your Biggest Gains In Q1 - Yahoo Finance
Gap Down: Can Definitive Healthcare Corp outperform under higher oil pricesJuly 2025 Update & Free Low Drawdown Momentum Trade Ideas - baoquankhu1.vn
Definitive Healthcare Stock Quote, Share Price, News and Analysis - Longbridge
Definitive Healthcare (DH) Earnings Transcript - AOL.com
Pullback Watch: Will Definitive Healthcare Corp benefit from current market trendsPortfolio Update Report & Weekly Watchlist of Top Performers - baoquankhu1.vn
Definitive Healthcare Corp. Hits New 52-Week Low at $1.14 - Markets Mojo
Tax-withholding share transfer by Definitive Healthcare (DH) CEO Coop - Stock Titan
Definitive Healthcare Earnings Call Balances Profit and Pressure - TipRanks
Canaccord Genuity Group Lowers Definitive Healthcare (NASDAQ:DH) Price Target to $3.00 - Defense World
DH PE Ratio & Valuation, Is DH Overvalued - Intellectia AI
Definitive Healthcare (NASDAQ:DH) Stock Rating Lowered by Wall Street Zen - Defense World
Definitive Healthcare Q4 2025 slides: profit gains amid revenue decline - Investing.com Australia
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
Stephens cuts Definitive Healthcare stock price target on revenue decline - Investing.com Nigeria
Canaccord Genuity Group Has Lowered Expectations for Definitive Healthcare (NASDAQ:DH) Stock Price - MarketBeat
Definitive Healthcare earnings missed by $0.15, revenue topped estimates - Investing.com South Africa
Stephens Cuts Definitive Healthcare (NASDAQ:DH) Price Target to $2.00 - MarketBeat
Deutsche Bank Adjusts Definitive Healthcare PT to $3 From $6, Maintains Hold Rating - marketscreener.com
Definitive Healthcare Corp. (DH) Stock Analysis: Exploring a 152% Potential Upside Opportunity - DirectorsTalk Interviews
Definitive Healthcare Corp. Q4 2025 Earnings Call Summary - Yahoo Finance
Stephens cuts Definitive Healthcare stock price target on revenue decline By Investing.com - Investing.com India
Definitive Healthcare Corp Azioni (DH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):